WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Anthony J. Sinskey net worth and biography

Anthony Sinskey Biography and Net Worth

Director of Yield10 Bioscience

Anthony J. Sinskey, Sc.D., a co-founder of Metabolix, has served as a director since June 1992. From 1968 to present, Dr. Sinskey has been on the faculty of MIT. Currently at MIT, he serves as professor of microbiology in the Department of Biology and professor of health sciences and technology in the Harvard-MIT Health Sciences and Technology Program Engineering Systems Division, as well as faculty director of the Center for Biomedical Innovation. Dr. Sinskey serves on the board of directors of Tepha, Inc. (see "Certain Relationships and Related Person Transactions"). Dr. Sinskey received a B.S. from the University of Illinois and a Sc.D. from MIT.

What is Anthony J. Sinskey's net worth?: The estimated net worth of Anthony J. Sinskey is at least $240.09 as of August 17th, 2022. Dr. Sinskey owns 721 shares of Yield10 Bioscience stock worth more than $240 as of December 25th. This net worth estimate does not reflect any other investments that Dr. Sinskey may own. Learn More about Anthony J. Sinskey's net worth.
How do I contact Anthony J. Sinskey?: The corporate mailing address for Dr. Sinskey and other Yield10 Bioscience executives is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. Yield10 Bioscience can also be reached via phone at (617) 583-1700 and via email at [email protected]. Learn More on Anthony J. Sinskey's contact information.
Has Anthony J. Sinskey been buying or selling shares of Yield10 Bioscience?: Anthony J. Sinskey has not been actively trading shares of Yield10 Bioscience over the course of the past ninety days. Most recently, on Wednesday, August 17th, Anthony J. Sinskey bought 83 shares of Yield10 Bioscience stock. The stock was acquired at an average cost of $67.20 per share, with a total value of $5,577.60. Following the completion of the transaction, the director now directly owns 721 shares of the company's stock, valued at $48,451.20. Learn More on Anthony J. Sinskey's trading history.
Who are Yield10 Bioscience's active insiders?: Yield10 Bioscience's insider roster includes Charles Haaser (CAO), and Anthony Sinskey (Director). Learn More on Yield10 Bioscience's active insiders.

Anthony J. Sinskey Insider Trading History at Yield10 Bioscience

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/17/2022	Buy	83	$67.20	$5,577.60	721
8/15/2022	Buy	83	$66.48	$5,517.84	554
3/14/2022	Buy	41	$149.52	$6,130.32
12/13/2021	Buy	83	$126.00	$10,458.00
12/9/2021	Buy	83	$119.76	$9,940.08
12/2/2021	Buy	83	$111.12	$9,222.96

Anthony J. Sinskey Buying and Selling Activity at Yield10 Bioscience

Yield10 Bioscience Company Overview

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

Today's Range

Now: $0.33

$0.32

$0.36

50 Day Range

MA: $0.52

$0.24

$1.00

2 Week Range

Now: $0.33

$0.31

$17.26

Volume

1,110 shs

Average Volume

78,164 shs

Market Capitalization

$244,422.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48